linvencorvir

Also Known As:

(8aS)-2,5,6,7,8,8a-hexahydro-1H-imidazo(1,5-a)pyrazin-3-one; RG7907

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Chronic Hepatitis B 10/01/2023 - "RO7049389 (linvencorvir) is a developmental oral treatment for chronic hepatitis B virus infection. "
2.	Infections 01/01/2023 - "Described herein is the first-time disclosure of Linvencorvir (RG7907), a clinical compound and a hepatitis B virus (HBV) core protein allosteric modulator, for the treatment of chronic HBV infection. " 01/01/2023 - "Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection."
3.	Hepatocellular Carcinoma (Hepatoma) 10/01/2023 - "RG7907 induced extensive HBc aggregation in vitro , in hepatoma cells, and in primary hepatocytes. "